ArticleThe Journal of clinical investigation2023

Linked CD4+/CD8+ T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regression.

Joseph S Dolina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.